vasopharm’s Traumatic Brain Injury Drug Exceeds Expectations in Phase IIa Exploratory Clinical Trial

Kontakt

Contact

HeidelbergCapital Asset Management GmbH

Der Turm

Alte Glockengießerei 9

D-69115 Heidelberg

Germany

Handelsregister Mannheim HRB 703921

Geschäftsführer:

Managing Directors:

Prof. Dr. Martin Weiblen, Dr. Clemens Doppler

GPS information:

Poststr. 15

69115 Heidelberg